Anti-Lyn (phospho Y507) 抗体 [EP504Y] (ab33914)

ab33914 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab33914 は 7 報の論文で使用されています。

  • Sharma N  et al. SHP2 phosphatase promotes mast cell chemotaxis toward stem cell factor via enhancing activation of the Lyn/Vav/Rac signaling axis. J Immunol 192:4859-66 (2014). PubMed: 24733849
  • Luo W  et al. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels. J Immunol 193:909-20 (2014). PubMed: 24929000
  • Clark MC  et al. Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death. Blood 120:4635-44 (2012). PubMed: 23065155
  • Lee EJ  et al. Capsiate inhibits ultraviolet B-induced skin inflammation by inhibiting Src family kinases and epidermal growth factor receptor signaling. Free Radic Biol Med 48:1133-43 (2010). PubMed: 20123015
  • Hussein K  et al. Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies. Ann Hematol 88:1059-67 (2009). PubMed: 19290526
  • McPherson VA  et al. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells. J Immunol 183:4940-7 (2009). PubMed: 19786542
  • Kinoshita T  et al. Protein purification and preliminary crystallographic analysis of human Lyn tyrosine kinase. Protein Expr Purif 58:318-24 (2008). PubMed: 18272395

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"